面向可持续的多学科肾癌肿瘤委员会:转诊路径的重新设计
该回顾性队列研究分析了2023年皇家自由肾癌专科中心2228例肾肿瘤患者的4154次SMDT讨论,发现多数患者讨论次数少且低复杂度病例可分流。据此设立SoC和良性MDT后,主SMDT每周讨论癌症患者数从83降至63,每患者讨论时间增加30.8%。
要点
- 低复杂度肾癌病例可分流至专门MDT以减轻主SMDT负担
- 分流后主SMDT每周讨论患者数下降,每例讨论时间增加
- 该分层转诊结构提升了多学科资源利用效率和可持续性
核心结论
- 按复杂度分层的MDT转诊结构通过将低复杂度协议化病例分流至专门的良性及标准治疗MDT,提高了效率和可持续性。
主要发现
- 96.3%的患者需要的讨论次数少于7次。
- 年龄>70岁且肾肿块<2 cm的患者常接受重复SMDT审查,而监测或保守管理是最常见的推荐。
- Bosniak I-II囊肿多被出院,Bosniak IIF囊肿主要以监测管理。
- 实施包含SoC和良性MDT的新转诊结构后,主SMDT每周讨论的癌症患者数从均值83降至63,每患者讨论时间增加30.8%。
- 新路径减少了协议化病例对完整SMDT出席的需求。
临床怎么用
- 可参照该模式设立标准治疗和良性MDT,将低复杂度协议化肾癌病例分流,使主SMDT专注于复杂决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and evaluate a complexity-stratified referral pathway aimed at improving the sustainability, efficiency and resource utilisation of specialist multidisciplinary team (SMDT) meetings within a high-volume tertiary renal cancer service. PATIENTS AND METHODS: We performed a retrospective cohort study of benign and malignant renal cancer cases discussed at SMDT meetings between January and December 2023 at the Royal Free Specialist Centre for Kidney Cancer. Patient demographics, tumour characteristics, SMDT discussions and management outcomes of patients were analysed to identify protocolised lower complexity cases suitable for alternative MDT pathways. Based on these findings, dedicated Standard of Care (SoC) and Benign MDTs were developed and implemented to manage lower complexity renal cases outside the main SMDT. The impact of the revised referral structure on SMDT workload, discussion efficiency and specialist resource utilisation was subsequently evaluated. RESULTS: In 2023, 2228 patients with benign and malignant renal pathology underwent 4154 SMDT discussions. Most patients (96.3%) required under seven discussions. Patients aged >70 years with renal masses <2 cm frequently underwent repeated SMDT review, despite surveillance or conservative management representing the most common management recommendation. Bosniak I-II cysts were predominantly discharged, whilst Bosniak IIF cysts were mainly managed with surveillance. Following implementation of the revised referral structure incorporating SoC and Benign MDTs, cases discussed at the main SMDT decreased from a mean of 83 to 63 patients with cancer per week, whilst discussion time per patient increased by 30.8%. The revised pathway also reduced the requirement for full SMDT attendance for protocolised cases. CONCLUSION: Complexity-stratified MDT referral structure improved efficiency and sustainability by diverting lower complexity protocolised cases to dedicated Benign and SoC MDTs. This enabled the main SMDT to prioritise clinically complex decision making and optimise utilisation of specialist multidisciplinary expertise.
引用
- Ghoshal B, Nalagatla S, Roberts M, et al. Towards sustainable multidisciplinary renal cancer tumour boards: redesigning the referral pathway. BJU Int. 2026. PMID: 42817743. doi:10.1111/bju.70451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。